These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 39294567)
1. Long COVID is not the same for everyone: a hierarchical cluster analysis of Long COVID symptoms 9 and 12 months after SARS-CoV-2 test. Moniz M; Ruivinho C; Goes AR; Soares P; Leite A BMC Infect Dis; 2024 Sep; 24(1):1001. PubMed ID: 39294567 [TBL] [Abstract][Full Text] [Related]
2. Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021. ; Wulf Hanson S; Abbafati C; Aerts JG; Al-Aly Z; Ashbaugh C; Ballouz T; Blyuss O; Bobkova P; Bonsel G; Borzakova S; Buonsenso D; Butnaru D; Carter A; Chu H; De Rose C; Diab MM; Ekbom E; El Tantawi M; Fomin V; Frithiof R; Gamirova A; Glybochko PV; Haagsma JA; Haghjooy Javanmard S; Hamilton EB; Harris G; Heijenbrok-Kal MH; Helbok R; Hellemons ME; Hillus D; Huijts SM; Hultström M; Jassat W; Kurth F; Larsson IM; Lipcsey M; Liu C; Loflin CD; Malinovschi A; Mao W; Mazankova L; McCulloch D; Menges D; Mohammadifard N; Munblit D; Nekliudov NA; Ogbuoji O; Osmanov IM; Peñalvo JL; Petersen MS; Puhan MA; Rahman M; Rass V; Reinig N; Ribbers GM; Ricchiuto A; Rubertsson S; Samitova E; Sarrafzadegan N; Shikhaleva A; Simpson KE; Sinatti D; Soriano JB; Spiridonova E; Steinbeis F; Svistunov AA; Valentini P; van de Water BJ; van den Berg-Emons R; Wallin E; Witzenrath M; Wu Y; Xu H; Zoller T; Adolph C; Albright J; Amlag JO; Aravkin AY; Bang-Jensen BL; Bisignano C; Castellano R; Castro E; Chakrabarti S; Collins JK; Dai X; Daoud F; Dapper C; Deen A; Duncan BB; Erickson M; Ewald SB; Ferrari AJ; Flaxman AD; Fullman N; Gamkrelidze A; Giles JR; Guo G; Hay SI; He J; Helak M; Hulland EN; Kereselidze M; Krohn KJ; Lazzar-Atwood A; Lindstrom A; Lozano R; Malta DC; Månsson J; Mantilla Herrera AM; Mokdad AH; Monasta L; Nomura S; Pasovic M; Pigott DM; Reiner RC; Reinke G; Ribeiro ALP; Santomauro DF; Sholokhov A; Spurlock EE; Walcott R; Walker A; Wiysonge CS; Zheng P; Bettger JP; Murray CJL; Vos T JAMA; 2022 Oct; 328(16):1604-1615. PubMed ID: 36215063 [TBL] [Abstract][Full Text] [Related]
3. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial. Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461 [TBL] [Abstract][Full Text] [Related]
4. Long COVID exhibits clinically distinct phenotypes at 3-6 months post-SARS-CoV-2 infection: results from the P4O2 consortium. Blankestijn JM; Abdel-Aziz MI; Baalbaki N; Bazdar S; Beekers I; Beijers RJHCG; Bloemsma LD; Cornelissen MEB; Gach D; Houweling L; Holverda S; Jacobs JJL; Jonker R; van der Lee I; Linders PMA; Mohamed Hoesein FAA; Noij LCE; Nossent EJ; van de Pol MA; Schaminee DW; Schols AMWJ; Schuurman LT; Sondermeijer B; Geelhoed JJM; van den Bergh JP; Weersink EJM; de Wit-van Wijck Y; Maitland-van der Zee AH; BMJ Open Respir Res; 2024 Apr; 11(1):. PubMed ID: 38663887 [TBL] [Abstract][Full Text] [Related]
5. Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study. Stephenson T; Pinto Pereira SM; Shafran R; de Stavola BL; Rojas N; McOwat K; Simmons R; Zavala M; O'Mahoney L; Chalder T; Crawley E; Ford TJ; Harnden A; Heyman I; Swann O; Whittaker E; ; Ladhani SN Lancet Child Adolesc Health; 2022 Apr; 6(4):230-239. PubMed ID: 35143770 [TBL] [Abstract][Full Text] [Related]
6. Profiling post-COVID-19 condition across different variants of SARS-CoV-2: a prospective longitudinal study in unvaccinated wild-type, unvaccinated alpha-variant, and vaccinated delta-variant populations. Canas LS; Molteni E; Deng J; Sudre CH; Murray B; Kerfoot E; Antonelli M; Rjoob K; Capdevila Pujol J; Polidori L; May A; Österdahl MF; Whiston R; Cheetham NJ; Bowyer V; Spector TD; Hammers A; Duncan EL; Ourselin S; Steves CJ; Modat M Lancet Digit Health; 2023 Jul; 5(7):e421-e434. PubMed ID: 37202336 [TBL] [Abstract][Full Text] [Related]
7. Characterisation, symptom pattern and symptom clusters from a retrospective cohort of Long COVID patients in primary care in Catalonia. Torrell G; Puente D; Jacques-Aviñó C; Carrasco-Ribelles LA; Violán C; López-Jiménez T; Royano V; Cantón AM; Medina-Perucha L; Rodríguez-Giralt I; Berenguera A BMC Infect Dis; 2024 Jan; 24(1):82. PubMed ID: 38225587 [TBL] [Abstract][Full Text] [Related]
9. Long COVID Clusters of Symptoms Persist beyond Two Years after Infection: Insights from the CARDIO COVID 20-21 Registry. Arango-Ibanez JP; Córdoba-Melo BD; Gutiérrez Posso JM; Barbosa-Rengifo MM; Herrera CJ; Quintana Da Silva MA; Buitrago AF; Coronel Gilio ML; Pow-Chong-Long F; Gómez-Mesa JE Viruses; 2024 Jun; 16(7):. PubMed ID: 39066191 [TBL] [Abstract][Full Text] [Related]
10. Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls (LongCOVIDKidsDK): a national, cross-sectional study. Kikkenborg Berg S; Dam Nielsen S; Nygaard U; Bundgaard H; Palm P; Rotvig C; Vinggaard Christensen A Lancet Child Adolesc Health; 2022 Apr; 6(4):240-248. PubMed ID: 35143771 [TBL] [Abstract][Full Text] [Related]
11. Associations between symptom-based long COVID clusters and long-term quality of life, work and daily activities among individuals testing positive for SARS-CoV-2 at a national retail pharmacy. Di Fusco M; Cappelleri JC; Yehoshua A; Craig KJT; Alvarez MB; Allen KE; Porter TM; Lopez SMC; Puzniak L; Sun X J Patient Rep Outcomes; 2024 Oct; 8(1):122. PubMed ID: 39436613 [TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India: a prospective, active surveillance study. Laxminarayan R; B CM; G VT; Arjun Kumar KV; Wahl B; Lewnard JA Lancet Infect Dis; 2021 Dec; 21(12):1665-1676. PubMed ID: 34399090 [TBL] [Abstract][Full Text] [Related]
13. Prognosis of patients with post-Covid-19 condition: Prospective cohort cluster analysis at one year. Liira H; Garner P; Malmivaara A; Kanerva M; Kvarnström K; Sainio M; Varonen M; Venäläinen M; Vuokko A; Arokoski J J Psychosom Res; 2024 Jul; 182():111808. PubMed ID: 38781803 [TBL] [Abstract][Full Text] [Related]
14. Cluster analysis of long COVID symptoms for deciphering a syndrome and its long-term consequence. Niewolik J; Mikuteit M; Klawitter S; Schröder D; Stölting A; Vahldiek K; Heinemann S; Müller F; Behrens G; Klawonn F; Dopfer-Jablonka A; Steffens S Immunol Res; 2024 Aug; 72(4):605-613. PubMed ID: 38627327 [TBL] [Abstract][Full Text] [Related]
15. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial. Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE; Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140 [TBL] [Abstract][Full Text] [Related]
16. Associations Between Acute COVID-19 Symptom Profiles and Long COVID Prevalence: Population-Based Cross-Sectional Study. Hirschtick JL; Slocum E; Xie Y; Power LE; Elliott MR; Orellana RC; Fleischer NL JMIR Public Health Surveill; 2024 Oct; 10():e55697. PubMed ID: 39352725 [TBL] [Abstract][Full Text] [Related]
17. Long COVID in a highly vaccinated but largely unexposed Australian population following the 2022 SARS-CoV-2 Omicron wave: a cross-sectional survey. Woldegiorgis M; Cadby G; Ngeh S; Korda RJ; Armstrong PK; Maticevic J; Knight P; Jardine A; Bloomfield LE; Effler PV Med J Aust; 2024 Apr; 220(6):323-330. PubMed ID: 38508863 [TBL] [Abstract][Full Text] [Related]
18. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial. Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE; Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099 [TBL] [Abstract][Full Text] [Related]
19. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae. LaVergne SM; Stromberg S; Baxter BA; Webb TL; Dutt TS; Berry K; Tipton M; Haberman J; Massey BR; McFann K; Alnachoukati O; Zier L; Heacock T; Ebel GD; Henao-Tamayo M; Dunn J; Ryan EP BMC Infect Dis; 2021 Jul; 21(1):677. PubMed ID: 34256735 [TBL] [Abstract][Full Text] [Related]
20. Long COVID symptoms in SARS-CoV-2-positive children aged 0-14 years and matched controls in Denmark (LongCOVIDKidsDK): a national, cross-sectional study. Kikkenborg Berg S; Palm P; Nygaard U; Bundgaard H; Petersen MNS; Rosenkilde S; Thorsted AB; Ersbøll AK; Thygesen LC; Nielsen SD; Vinggaard Christensen A Lancet Child Adolesc Health; 2022 Sep; 6(9):614-623. PubMed ID: 35752194 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]